Search research articles
Contact Us
Filters
Showing results (41-50 of 476) with videos related to
Page
of 48
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2008
Chemotherapy for advanced prostate cancer: 25 years later
Christopher J Logothetis, Randall Millikan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2016
Is It Time to Re-Examine the Prostate Cancer Treatment Paradigm by Targeting the Interaction Between the Prostate and Metastases?
Christopher J Logothetis, Ana M Aparicio
Nature Reviews. Cancer
|
January 5, 2005
Osteoblasts in prostate cancer metastasis to bone
Christopher J Logothetis, Sue-Hwa Lin
Cancer Research
|
August 4, 2004
Bortezomib as a potential treatment for prostate cancer
Christos N Papandreou, Christopher J Logothetis
Cancer Prevention Research (Philadelphia, Pa.)
|
January 14, 2009
High-grade prostate cancer and the prostate cancer prevention trial
Christopher J Logothetis, Paul F Schellhammer
European Urology
|
March 27, 2024
Reply to Richard J. Wassersug, Paul F. Schellhammer, and Erik Wibowo's Letter to the Editor re: Christoper J. Logothetis, Andrew W. Hahn. Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome. Eur Urol 2024;85:3-7
Christopher J Logothetis, Andrew W Hahn
European Urology
|
May 20, 2023
Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome
Christopher J Logothetis, Andrew W Hahn
European Urology
|
October 23, 2010
Words of wisdom. Re: final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium
Christopher J Logothetis, Arlene Siefker-Radtke
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2011
Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic response
Charles J Ryan, Shreya Shah, Eleni Efstathiou, et al.
Future Oncology (London, England)
|
November 18, 2024
The landscape of androgen deprivation therapies for the treatment of advanced prostate cancer
Neal D Shore, Michael S Cookson, Eleni Efstathiou
Page
of 48
Search research articles
Search
Showing results (41-50 of 476) with videos related to
Sort By:
Page
of 48
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2008
Chemotherapy for advanced prostate cancer: 25 years later
Christopher J Logothetis, Randall Millikan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2016
Is It Time to Re-Examine the Prostate Cancer Treatment Paradigm by Targeting the Interaction Between the Prostate and Metastases?
Christopher J Logothetis, Ana M Aparicio
Nature Reviews. Cancer
|
January 5, 2005
Osteoblasts in prostate cancer metastasis to bone
Christopher J Logothetis, Sue-Hwa Lin
Cancer Research
|
August 4, 2004
Bortezomib as a potential treatment for prostate cancer
Christos N Papandreou, Christopher J Logothetis
Cancer Prevention Research (Philadelphia, Pa.)
|
January 14, 2009
High-grade prostate cancer and the prostate cancer prevention trial
Christopher J Logothetis, Paul F Schellhammer
European Urology
|
March 27, 2024
Reply to Richard J. Wassersug, Paul F. Schellhammer, and Erik Wibowo's Letter to the Editor re: Christoper J. Logothetis, Andrew W. Hahn. Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome. Eur Urol 2024;85:3-7
Christopher J Logothetis, Andrew W Hahn
European Urology
|
May 20, 2023
Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome
Christopher J Logothetis, Andrew W Hahn
European Urology
|
October 23, 2010
Words of wisdom. Re: final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium
Christopher J Logothetis, Arlene Siefker-Radtke
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2011
Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic response
Charles J Ryan, Shreya Shah, Eleni Efstathiou, et al.
Future Oncology (London, England)
|
November 18, 2024
The landscape of androgen deprivation therapies for the treatment of advanced prostate cancer
Neal D Shore, Michael S Cookson, Eleni Efstathiou
Page
of 48